Page last updated: 2024-09-04

bcx 1812 and (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone

bcx 1812 has been researched along with (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone in 1 studies

Compound Research Comparison

Studies
(bcx 1812)
Trials
(bcx 1812)
Recent Studies (post-2010)
(bcx 1812)
Studies
((3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone)
Trials
((3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone)
Recent Studies (post-2010) ((3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone)
2511238115

Protein Interaction Comparison

ProteinTaxonomybcx 1812 (IC50)(3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone (IC50)
Histone deacetylase 3Homo sapiens (human)0.0151
Cytochrome P450 1A2Homo sapiens (human)0.011
Cytochrome P450 3A4Homo sapiens (human)0.011
Cytochrome P450 2D6Homo sapiens (human)0.034
Cytochrome P450 2C9 Homo sapiens (human)0.034
Tissue factorHomo sapiens (human)0.175
Cytochrome P450 2B6Homo sapiens (human)0.034
Cytochrome P450 3A5Homo sapiens (human)0.011
Cytochrome P450 2C19Homo sapiens (human)0.011
Histone deacetylase 4Homo sapiens (human)1.0335
Histone deacetylase 1Homo sapiens (human)0.0227
Histone deacetylase 7Homo sapiens (human)0.014
Histone deacetylase 2Homo sapiens (human)0.0185
Polyamine deacetylase HDAC10Homo sapiens (human)0.014
Histone deacetylase 11 Homo sapiens (human)0.014
Histone deacetylase 8Homo sapiens (human)0.2852
Histone deacetylase Cryptosporidium parvum0.001
Histone deacetylase Cryptosporidium parvum0.001
Histone deacetylase 6Homo sapiens (human)1.4663
Histone deacetylase 9Homo sapiens (human)0.014
Histone deacetylase 5Homo sapiens (human)0.014
Histone deacetylase Plasmodium falciparum (malaria parasite P. falciparum)0.001
Nuclear receptor corepressor 2Homo sapiens (human)0.0193

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for bcx 1812 and (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023